Cruz Tapia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe

MONTPELLIER, France, July 19, 2023 Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe

United kingdomFrance generalCruz tapiaStuart isabelle abdouNawal ouzrenInstitut pasteurPierre louis germainEu community registerCommunications europe franceConsilium strategic communicationsEuropean medicines agencyRegulatory agencyDrug administrationInternational media relationsRegulatory newsClinical trial application

Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK

Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomNawal ouzrenPierre louis germainInstitut pasteurCruz tapiaStuart isabelle abdouEu community registerEuropean medicines agencyCommunications europe franceConsilium strategic communicationsDrug administrationRegulatory agencyInternational media relationsRegulatory newsClinical trial application

Sensorion receives Orphan Drug Designation for OTOF-GT for the treatment of otoferlin gene-mediated hearing loss from the US Food and Drug Administration

Designation follows recent FDA award of Rare Pediatric Disease Designation to Sensorion for OTOF-GT program Sensorion is on track to file a CTA for OTOF-GT in H1 2023 Regulatory News:

Cruz tapiaInstitut pasteurNoemie djokovicMatthew cole jessica hodgsonEuropean medicines agencyEuropean commissionDrug administrationInternational media relationsConsilium strategic communicationsRare pediatric disease designationOrphan drug designationClinical trial applicationRare pediatric diseaseDrug designationChief medical officerCisplatin induced ototoxicity